Common drugs may influence motor recovery after stroke

Neurology

Volumn 45, Issue 5, 1995, Pages 865-871

  Goldstein, Larry B ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HYPOCHOLESTEROLEMIC AGENT; IDAZOXAN; INSULIN; LAXATIVE; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; PHENOBARBITAL; PHENYTOIN; PRAZOSIN; THEOPHYLLINE; THYROXINE; UNINDEXED DRUG; YOHIMBINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; STROKE;

AGED; ANALYSIS OF VARIANCE; CEREBROVASCULAR DISORDERS; DOUBLE-BLIND METHOD; DRUG THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGE; MOVEMENT; MUSCLES; TIME FACTORS;

EID: 0029019189     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.45.5.865     Document Type: Article

References (40)

1. Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol 1987;3:135- 197.
2. Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast 1993;4:175-192.
3. Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 1985;342:352-356.
4. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperi- dol, and experience interact to affect the rate of recovery after motor cortex injury. Science 1982;217:855-857.
5. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984;298:358-361.
6. Goldstein LB. Pharmacology of recovery after stroke. Stroke 1990;21(suppl III):139-142.
7. Goldstein LB, Davis JN. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restorative Neurol Neurosci 1990;1:311-314.
8. Goldstein LB. Amphetamine-facilitated functional recovery after stroke. In: Ginsberg MD, Dietrich WD, eds. Cerebrovascular diseases. Sixteenth Research (Princeton) Conference. New York: Raven Press, 1989:303-308.
9. Feeney DM, Westerberg VS. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990;44:233-252.
10. Goldstein LB, Poe HV, Davis JN. An animal model of recovery of function after stroke: facilitation of recovery by an a2- adrenergic receptor antagonist [abstract]. Ann Neurol 1989;26:157.
11. Sutton RL, Feeney DM. a-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. Restorative Neurol Neurosci 1992;4:1-11.
12. Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking in rats. Brain Res 1990,508:305-309.
13. Brailowsky S, Knight RT, Blood K. -y-Aminobutyric acid-induced potentiation of cortical hemiplegia. Brain Res 1986;362:322-330.
14. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986;376:71-77.
15. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 1986;379:104-111.
16. Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res 1994;635:300-306.
17. Goldstein LB, Davis JN. Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. Neurology 1988;38:1806-1809.
18. Crisostomo EA, Duncan PW, Propst MA, Dawson DB, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988;23:94-97.
19. Walker-Batson D, Unwin H, Curtis S, et al. Use of amphetamine in the treatment of aphasia. Restorative Neurol Neurosci 1992;4:47-50.
20. Goldstein LB, Matchar DB, Morgenlander JC, Davis JN. The influence of drugs on the recovery of sensorimotor function after stroke. J Neuro Rehab 1990;4:137-144.
21. Porch BE, Feeney DM. Effects of antihypertensive drugs on recovery from aphasia. Clin Aphasiology 1986;16:309-314.
22. The SASS Investigators. Ganglioside GMj in acute ischemic stroke: the SASS trial. Stroke 1994;25:1141-1148.
23. Lincoln NB, Blackburn M, Ellis S, et al. An investigation of factors affecting progress of patients on a stroke unit. J Neurol Neurosurg Psychiatry 1989;52:493-496.
24. Norris JW. Comments on ‘study design of stroke treatments.’ Stroke 1982;13:527-528.
25. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Maryland State Med J 1965;14:61-65.
26. Schwartz JA, Speed NM, Brunberg JA, Brewer TL, Brown M, Greden JF. Depression in stroke rehabilitation. Biol Psychiatry 1993;33:694-699.
27. Heinemann AW, Roth EJ, Cichowski K, Betts HB. Multivariate analysis of improvement and outcome following stroke rehabilitation. Arch Neurol 1989;44:1167-1172.
28. Chollet F, DiPiero V, Wise RJS, Brooks DJ, Dolan RJ, Frackowiak RSJ. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991;29:63-71.
29. Dietrich WD, Alonso O, Busto R, Ginsberg MD. Influence of amphetamine treatment on somatosensory function of the normal and infarcted rat brain. Stroke 1990;21(suppl III):147-150.
30. Feeney DM, Baron J-C. Diaschisis. Stroke 1986;17:817-830.
31. Castella Y, Dietrich WD, Watson BD, Busto R. Acute thrombotic infarction suppresses metabolic activation of ipsilateral somatosensory cortex: evidence for functional diaschisis. J Cereb Blood Flow Metab 1989;9:329-341.
32. Martin WRW, Raichle ME. Cerebellar blood flow and metabolism in cerebral hemisphere infarction. Ann Neurol 1983;14:168-176.
33. Bliss TVP, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973;232:331-356.
34. Hopkins WF, Johnston D. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 1984;226:350-352.
35. Everitt BJ, Robbins TW, Gaskin M. The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat. Neuroscience 1983;10:397-410.
36. Stein L, Beluzzi JD, Wise CD. Memory enhancement by cental administration of norepinephrine. Brain Res 1975;84:329-335.
37. Goldstein LB, Coviello A. Post-lesion administration of the NMDA receptor antagonist MK-801 does not impair motor recovery after unilateral sensorimotor cortex injury in the rat. Brain Res 1992;580:129-136.
38. Wagner HR, Davis JN. Beta-adrenergic receptor regulation by agonists and membrane depolarization in rat brain slices. Proc Natl Acad Sci U S A 1979;76:2057-2061.
39. Zucker RS. Short-term synaptic plasticity. Annu Rev Neu- rosci 1989;12:13-31.
40. Schallert T, Jones TA, Weaver MS, Shapiro LE, Crippens D, Fulton R. Pharmacologic and anatomic considerations in recovery of function. Phys Med Rehabil 1992;6:375-393.